NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-285-2002-0-MX-20 Lutzomyia Longipalpis Polypeptides and Methods of Use MX DIV MX/a/2010/000185 Expired
NIAID E-172-2007-2-US-02 Aegyptin and Uses Thereof US National Stage 12/668,177 8383589 Issued PDF
NIAID E-335-2003-1-US-10 Mechanisms For Improving The Breadth Of The Immune Response To Diverse Strains And Clades Of HIV US CON 12/683,844 7947822 Abandoned PDF
NCI E-086-2010-0-US-01 Prostate Tumor-Associcated Dendritic Cell Induction of Tolerance and Suppressor Activity in Tumor... - US 61/293,098 Abandoned
NCI E-103-2007-0-US-03 Improved DNA Vaccination Protocol US National Stage 12/522,775 8586055 Issued PDF
NIA E-016-2009-0-US-02 Nucleic Acid Modules for Expression and Tagging of Membrane Proteins and Methods of Use US ORD 12/652,395 8501925 Abandoned PDF
NIDCD E-201-2007-2-US-01 Combination Of Treatments For More Efficient Novel Cancer Treatment Principle US CIP 12/667,687 8680129 Issued PDF
NCI E-137-2002-0-US-10 METHODS FOR TREATING CANCER IN HUMANS US DIV 12/651,858 Abandoned
NIAID E-204-2008-0-PCT-02 LJL143 Sand Fly Salivary Proteins As Novel Factor Xa Inhibitors and Methods Of Use PCT PCT PCT/US2009/069877 Abandoned
NIAID E-205-2008-0-PCT-02 Sand Fly Salivary Proteins (LJM04, LJM11, LJM26, LJL143, And LJMI9) With Anti-complement Activity And Methods of Their Use PCT PCT PCT/US2009/069874 Abandoned
NIEHS E-255-2007-0-US-05 Detecting And Controlling Abnormal Hematopoiesis US National Stage 12/667,287 Abandoned
NEI E-241-1999-0-US-07 Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices US DIV 12/647,980 Abandoned
NHLBI E-253-2009-0-US-01 Compisite Probes and Use Thereof in Super Resolution Methods US 61/290,282 Abandoned
NCI E-141-2008-0-IL-04 ISOLATED CELLS THAT RECOMBINANTLY EXPRESS MAMMALIAN IL-15 AND IL-15RALPHA IL National Stage 202997 Issued
NCI E-141-2008-0-JP-05 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof JP National Stage 2010-514839 Abandoned
NIA E-354-2004-0-US-08 Protomic Profiles Associated With Osteoarthritis And Aging US DIV 12/647,166 Abandoned
NIAID E-300-2009-2-US-01 Neutralizing Antibodies Against HIV-1 And Their Use US 61/290,135 Abandoned
NCI E-141-2008-0-NZ-06 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof NZ National Stage 582330 Issued
NICHD E-254-2009-0-US-01 Identification OfNovel Thermostable Y-Family Polymerases From Fungi. US 61/289,901 Abandoned
NCI E-154-2009-0-PCT-02 INHIBITORS OF MRE11, RAD50 AND/OR NBS1 PCT PCT PCT/US09/69171 Abandoned
NCI E-325-2008-0-PCT-02 Survivin Specific T Cell Receptor For Immunotherapy Of Cancer PCT PCT PCT/US2009/69248 Abandoned
NCI E-042-2006-0-US-14 Protective Complement Proteins and Age-related Macular Degeneration US CON 12/645,272 Abandoned
NIEHS E-334-2008-0-PCT-02 Artificial Splicing Factors With PUF Protein RNA-binding Domain And Splicing Effector Domains PCT PCT PCT/US2009/69041 Abandoned
NINDS E-160-2009-2-CA-03 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis CA National Stage 2760338 Abandoned
NINDS E-160-2009-2-CY-12 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis CY EP 09795720.3 Abandoned
NINDS E-160-2009-2-CZ-13 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis CZ EP 09795720.3 Abandoned
NINDS E-160-2009-2-BG-10 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis BG EP 09795720.3 Abandoned
NINDS E-160-2009-2-HR-21 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis HR EP 09795720.3 Abandoned
NINDS E-160-2009-2-PL-35 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis PL EP 09795720.3 Abandoned
NINDS E-160-2009-2-MT-32 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis MT EP 09795720.3 Abandoned
NINDS E-160-2009-2-SK-40 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis SK EP 09795720.3 Abandoned
NINDS E-160-2009-2-MK-31 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis MK EP 09795720.3 Abandoned
NINDS E-160-2009-2-PT-36 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis PT EP 09795720.3 Abandoned
NINDS E-160-2009-2-SI-39 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis SI EP 09795720.3 Abandoned
NINDS E-160-2009-2-NO-34 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis NO EP 09795720.3 Abandoned
NINDS E-160-2009-2-RO-37 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis RO EP 09795720.3 Abandoned
NINDS E-160-2009-2-SM-41 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis SM EP 09795720.3 Abandoned
NINDS E-160-2009-2-NL-33 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis NL EP 09795720.3 Abandoned
NINDS E-160-2009-2-MC-30 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis MC EP 09795720.3 Abandoned
NINDS E-160-2009-2-CH-11 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis CH EP 09795720.3 Abandoned
NINDS E-160-2009-2-ES-17 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis ES EP 09795720.3 Abandoned
NINDS E-160-2009-2-TR-42 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis TR EP 09795720.3 Abandoned
NINDS E-160-2009-2-SE-38 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis SE EP 09795720.3 Abandoned
NINDS E-160-2009-2-GB-20 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis GB EP 09795720.3 Abandoned
NINDS E-160-2009-2-HU-22 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis HU EP 09795720.3 Abandoned
NINDS E-160-2009-2-IE-23 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis IE EP 09795720.3 Abandoned
NINDS E-160-2009-2-IS-24 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis IS EP 09795720.3 Abandoned
NINDS E-160-2009-2-IT-25 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis IT EP 09795720.3 Abandoned
NINDS E-160-2009-2-LT-27 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis LT EP 09795720.3 Abandoned
NINDS E-160-2009-2-LV-29 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis LV EP 09795720.3 Abandoned